Results 1-9 of 9 (Search time: 0.003 seconds).
Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2022 | Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs | Nicholson, MW; Huang, CY; Wang, JY; Ting, CY; Cheng, YC; Chan, DZH; Lee, YC; Hsu, CC; Hsu, YH; Chang, CMC; Hsieh, ML; Cheng, YY; Lin, YL ; Chen, CH ; Wu, YT ; Hacker, TA; Wu, JC; Kamp, TJ; Hsieh, PCH | Pharmaceuticals. 15(6), 765 | |||
2 | 2022 | Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons | Huang, CY; Nicholson, MW; Wang, JY; Ting, CY; Tsai, MH; Cheng, YC; Liu, CL; Chan, DZH; Lee, YC; Hsu, CC; Hsu, YH; Yang, CF; Chang, CM; Ruan, SC; Lin, PJ; Lin, JH; Chen, LL; Hsieh, ML; Cheng, YY; Hsu, WT; Chen, CH ; Hsu, YH; Wu, YT ; Hacker, TA; Wu, JC; Kamp, TJ; Hsieh, PC | Cell Reports 39(1), 110643 | |||
3 | 2018 | Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant | Cheng, YC; Huang, CY; Ho, MC; Hsu, YH; Syu, SH; Lu, HE; Lin, HI; Lin, CH; Hsieh, PC | Stem Cell Research 28, 1-5 | |||
4 | 2018 | Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old sialidosis patient with NEU-1 gene mutation | Liu, SP; Hsu, YH; Huang, CY; Ho, MC; Cheng, YC; Wen, CH; Lu, HE; Tsai, CH; Shyu, WC; Hsieh, PC | Stem Cell Research 28, 39-43 | |||
5 | 2017 | Generation of an induced pluripotent stem cell line from a 39-year-old female patient with severe-to-profound non-syndromic sensorineural hearing loss and a A1555G mutation in the mitochondrial MTRNR1 gene | Hsu, YH; Wu, YT; Huang, CY; Ho, MC; Cheng, YC; Syu, SH; Lu, HE; Chen, YC; Tsai, CL; Lin, HC; Wei, YH; Hsu, YC; Hsieh, PC | Stem Cell Research 25, 245-249 | |||
6 | 2017 | Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation | Lin, CH; Cheng, YC; Lin, HI; Ho, MC; Hsu, YH; Wen, CH; Ko, HW; Lu, HE; Huang, CY; Hsieh, PC | Stem Cell Research 25, 123-127 | |||
7 | 2017 | Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2 | Ho, MC; Huang, CY; Lee, JJ; Hsu, SH; Cheng, YC; Hsu, YH; Hwang, DY; Lu, HE; Chen, HC; Hsieh, PC | Stem Cell Research 25, 38-41 | |||
8 | 2017 | Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation | Lee, JJ; Ho, MC; Huang, CY; Wen, CH; Cheng, YC; Hsu, YH; Hwang, DY; Lu, HE; Chen, HC; Hsieh, PC | Stem Cell Research 25, 83-87 | |||
9 | 2017 | Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1 | Huang, CY; Ho, MC; Lee, JJ; Hwang, DY; Ko, HW; Cheng, YC; Hsu, YH; Lu, HE; Chen, HC; Hsieh, PC | Stem Cell Research 24, 139-143 |